US FDA Approves Two New Drug Applications Of Lupin
On Friday, 6th May 2022, Lupin, pharmaceutical company announced that, it is now received the approval from the Food and Drug Administration (FDA) of the United States for the iloperidone and pregabalins tablets. The pregabalin capsules have been used for treating anxiety and epilepsy and as Iloperidone tablets have been used for the purpose of […]
Continue Reading